Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise and supporting infrastructure to manufacture a wide variety of radioisotopes, for in-house use, or as a contract service, claims Roots Analysis

Written by

The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.


To order this 320+ page report, which features 45+ figures and 100+ tables, please visit


The USD 6+ billion (by 2030) financial opportunity associated with nuclear medicine and radiopharmaceuticals manufacturing, has been analyzed across the following segments:

  • Target Disease Indication
  • Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Lupus Nephritis
  • Melanoma
  • Multiple Myeloma
  • Primary Sjögren’s Syndrome
  • Others


  • Target Immune Checkpoint
  • B7-H3
  • CD38
  • CD40
  • CD47
  • Others


  • Mechanism of Action
  • Inhibitory
  • Stimulatory


  • Therapeutic Modality
  • Monoclonal Antibody
  • Small Molecule


  • Type of Therapy
  • Monotherapy
  • Combination Therapy


  • Route of Administration
  • Intravenous
  • Subcutaneous
  • Others


  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific and the Rest of the World


The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • Advanced Accelerator Applications
  • Belgian Nuclear Research Center (SCK•CEN)
  • Cardinal Health
  • China Isotope & Radiation Corporation
  • Curium Pharma
  • DuChemBio
  • Eckert & Ziegler
  • Eczacibasi-Monrol
  • GE Healthcare
  • Jubilant DraxImage
  • Lantheus Medical Imaging
  • Nihon Medi-Physics
  • Nordion
  • PETNET Solutions
  • SinoTau Pharmaceuticals


Table of Contents


  1. Preface

    2. Executive Summary

  2. Introduction
  3. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape
  4. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Non-Industry Players): Current Market Landscape
  5. Nuclear Medicine and Radiopharmaceuticals Manufacturers in North America
  6. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Europe
  7. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World
  8. Nuclear Medicine and Radiopharmaceuticals Manufacturers: Company Competitiveness Analysis
  9. Partnerships and Collaborations
  10. Production and Supply Chain of Medical Isotope Molybdenum-99 (Technetium-99m)
  11. Market Forecast and Opportunity Analysis
  12. Concluding Remarks


  1. Executive Insights


  1. Appendix 1: Tabulated Data


  1. Appendix 2: List of Companies and Organizations


To purchase a copy, please visit


About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]


Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Facebook –

LinkedIn –

Twitter –


Medium –

Pinterest –

Quora –

Article Tags:
· · ·
Article Categories:

Leave a Reply

Your email address will not be published. Required fields are marked *